This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Results:Between 2017 and 2022, 1,283,435 CVD cases were notified (SAH=4,7%; ICH= 8.8%; and ischemic stroke=86.5%). Rates of Thrombolysis were alarming, but with an increasing tendency: 22969 were performed, from 1.6% in 2017 to 2.3% in 2017 to 2.3% in 2017 to R$ 537,511,793.62 were Male and 47.6% were Female.
Introduction:Intravenous thrombolysis with alteplase (tPA) or tenecteplase (TNK) is a first-line treatment for acute ischemic stroke. We reviewed stroke databases from 2017 to 2024 for patients who received IV thrombolysis with either tPA or TNK and developed sICH within 36 hours of treatment.
Background:We studied the effect of intravenous thrombolysis (IVT) before thrombectomy for anterior circulation large vessel occlusion (acLVO) on functional outcome and scrutinized its dependence on grade of reperfusion and distal thrombus migration.Methods:We included consecutive acLVO patients from our prospective registry of thrombectomy-eligible (..)
The role of adjunctive intravenous thrombolysis, such as intravenous tissue plasminogen activator (IVtPA), with MT remains unclear, especially for medium vessel occlusion (MeVO). Background:Mechanical thrombectomy (MT) has demonstrated superiority over medical therapy for acute ischemic stroke (AIS) with large vessel occlusion (LVO).
This study addresses this gap in the literature by evaluating the effectiveness of those prognostic tools in stroke patients treated in a rural area of the Midwest.Methods:We conducted a retrospective study of stroke patients treated with thrombolytics at Southern Illinois Healthcare Stroke Network from July 2017 to June 2024.
Linear regression identified prepercutaneous coronary intervention Thrombolysis in Myocardial Infarction flow (=3.35,P<0.001) CONCLUSIONS:EGE-derived MSI was associated with prepercutaneous coronary intervention Thrombolysis in Myocardial Infarction flow and microvascular injuries.
of these patients received IV thrombolysis and 32.4% received IV thrombolysis and 43.9% Patients with LVO on CTA or MRA at presentation were included. We then assessed patients with LAA and compared their discharge destination to patients with other etiologies.Results:Out of 1210 patients with AIS, 172 with LVO were included.
A t-test was used to examine association between outcomes and thrombolysis type. p=0.383) were similar for all patients receiving TNK and TPA, respectively.Conclusions:In our retrospective analysis, TNK showed a higher rate of TICI 3 recanalization for patients with LVO, who both received thrombolysis and underwent MT. versus 16.0,
Our investigation focused on delineating the distinctive features of ICAS-related LVOS to explore its underlying pathology.Methods:This is a cross-sectional comparison from a prospective, single-center cohort study of acute ischemic stroke from January 2017 to January 2023. Among patients with lower fibrinogen levels (< 3.2g/L),
Methods:We conducted a multinational study analyzing data from the MAD-MT registry, encompassing 37 centers across North America, Asia, and Europe, collected between September 2017 and July 2023.
Methods:STEMI patients who underwent coronary revascularization therapy and cardiac magnetic resonance (CMR) at about 4 days and 6 months between 2017 and 2023 were included.
This study compares post-thrombectomy outcomes in both groups, matched by initial NIHSS scores.Method:From October 2017 to March 2023, we studied LVO cases undergoing thrombectomy for acute ischemic stroke. Successful recanalization was defined as Thrombolysis in Cerebral Ischemia score ≥2b. However, clinical outcomes remain similar.
Pre-transfer variables independently associated with clinical improvement were intravenous thrombolysis use, more distal occlusions, and lower serum glucose; variables associated with deterioration included more proximal occlusions and higher serum glucose.
This study is aimedaims at to establishing MSU time metrics and implementing strategies to improve the efficiency of prehospital stroke care.Methods:We analyzed data from 289 patients admitted to the MSU between the years of 2017-2023.
Methods:From our prospectively collected multi-center registry across four comprehensive stroke centers (CSC) in the Greater Houston area, we identified patients from 2017 to 2023 with LVO AIS who received EVT. FIV was defined using MRI DWI at 48 hours. Large infarct core was defined by CTP as exceeding 70 ml or by CT ASPECTS < 6.
Regional collateral status on initial angiogram, expanded Thrombolysis in Cerebral Infarction (eTICI) grade on final angiogram, and regional unfavorable tissue outcome with the appearance of low or high density on CT 24 h after MT were recorded.
2017 Mar 13;10(5):e47-e49. Epub 2017 Feb 15. David Smith, Ayush Khurana, Aprim Youhana, Adrian Ionescu, Kissing Balloon “Valvuloplasty” of Obstructed Mechanical Aortic Valve: When You Are Running Out of Options, JACC: Case Reports,Volume 4, Issue 13, 2022, Pages 799-801, 2.Kandzari Kandzari DE, Carlson H, Gott JP, Kaul P, Brown WM.
Discovering discrepancies in a major published trial from the pharma-academic complex would be a boost to those seeking to force trial data to be public, and that is exactly what a group of investigators attempted to do with a major cholesterol lowering trial published in 2017. But first, some background. Cholesterol lowering is big business.
European Heart Journal 38(41):3082-3089; November 1, 2017. Blinded physicians adjudicated angiogram reports for coronary lesions and thrombolysis in myocardial infarction (TIMI) flow score. Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analys is.
Jeffery Dormu was a double board certified vascular surgeon who was paid $13 million dollars by Medicare alone between 2013 and 2017. A thrombolysis is performed in the hospital via a catheter. Propublica does a much better job in their deep-dive into the PAD story which focuses on vascular surgeon Jeffery Dormu. 4.8.2017.
The observation period was divided into 4 epochs: 2008 to 2010, 2011 to 2013, 2014 to 2016, and 2017 to 2019. Intravenous thrombolysis and mechanical thrombectomy rates increased over time from 2008 to 2010 to 2017 to 2019 (9.5%–13.8% in 2017–2019) and 3-month modified Rankin Scale scores 0 to 1 (68.3%–69.1%)
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content